Emisphere Technologies, Inc. Logo
Emisphere Reports Third Quarter 2015 Financial Results
November 16, 2015 07:55 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the third quarter ended September 30, 2015, and provided a corporate...
Emisphere Technologies, Inc. Logo
Emisphere Announces Third Quarter 2015 Financial Results Conference Call
November 10, 2015 16:35 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that Management will host a conference call on Monday, November 16, 2015, at 8:30 AM ET to...
Emisphere Technologies, Inc. Logo
Emisphere to Present at SeeThruEquity MicroCap Investor Forum
November 05, 2015 16:15 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the...
Emisphere Technologies, Inc. Logo
Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement
October 15, 2015 08:20 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. today announced that it has entered into a Development and License Agreement with Novo Nordisk A/S (NYSE:NVO) to...
Emisphere Technologies, Inc. Logo
Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference
September 02, 2015 16:15 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the Rodman and...
Emisphere Technologies, Inc. Logo
Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1
August 26, 2015 09:38 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today highlighted that Eligen® licensee Novo Nordisk A/S (NYSE:NVO) will initiate a global phase 3a...
Emisphere Technologies, Inc. Logo
Emisphere Reports Second Quarter 2015 Financial Results
August 12, 2015 08:00 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the quarter ended June 30, 2015, and provided a corporate...
Emisphere Technologies, Inc. Logo
Emisphere Announces Second Quarter 2015 Financial Results Conference Call
August 06, 2015 16:30 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that Management will host a conference call on Wednesday, August 12, 2015, at 8:30 AM ET to...
Emisphere Technologies, Inc. Logo
Emisphere Reports First Quarter 2015 Financial Results
May 15, 2015 08:00 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., May 15, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the first quarter ended March 31, 2015, and provided an overview of...
Emisphere Technologies, Inc. Logo
Emisphere Announces First Quarter 2015 Financial Results Conference Call
May 11, 2015 16:15 ET | Emisphere Technologies, Inc.
ROSELAND, N.J., May 11, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that management will host a conference call on Friday, May 15, 2015, at 8:30 AM EDT to...